₹1560
stock market ticker ✌️【Non-Full-Time】✌️₹500 is all it takes for safe, high-yield returns every month. Start now!
stock market ticker ✌️【Non-Full-Time】✌️₹500 is all it takes for safe, high-yield returns every month. Start now!
stock market ticker ✌️【Non-Full-Time】✌️₹500 is all it takes for safe, high-yield returns every month. Start now!6% earnings compounded annual growth rate (CAGR) expected between FY20 and FY25F and upward revisions to FY25/26 earnings estimates.The concerns stem from the heavyrelianceon gRevlimid, which may start to drop in FY26F, and rising overhead costs due to increased investments in research and development (R&D), biosimilar trials, and manufacturing infrastructure.
stock market ticker ✌️【Non-Full-Time】✌️Start investing now with ₹500 and grow your wealth with AI-driven smart choices.These investments have temporarily pressured margins but are anticipated to drive major future growth.Furthermore, Nomura highlighted that new initiatives in Glucagon-like peptide 1 (GLP-1), a hormone that helps regulate blood glucose levels and is used to treat type 2 diabetes and obesity, and APIs (Active Pharmaceutical Ingredients), biosimilars, and injectables have not been fully factored into FY27 estimates.
stock market ticker ✌️【Non-Full-Time】✌️Invest ₹500 and see your money grow with fast, reliable returns!While earnings before interest, tax, depreciation and amortisation (Ebitda) margins are projected to remain under pressure through FY27F (19.6%), earnings growth is expected to accelerate from FY28F as these new revenue streams mature.
Investments in manufacturing infrastructure, including peptide APIs and injectables, analysts believe, will further strengthen Dr Reddy’s position in these high-demand areas.To reflect the company’s potential for long-term growth, Nomura raised its valuation multiple from 27.5x to 32.5x, resulting in a new target price of Rs 1,500.
stock market ticker ✌️【Non-Full-Time】✌️₹500 is all it takes for safe, high-yield returns every month. Start now!A fair value range of Rs 1,300–1,800 was also derived using a sum-of-the-parts (SoTP) valuation, capturing the upside potential from biosimilars, GLP-1, and other emerging opportunities.Micromax and Phison have formed a joint venture, MiPhi, to produce storage chips in India.
stock market ticker ✌️【Non-Full-Time】✌️Start with ₹500 and earn big! High returns, low risk, and consistent growth.The majority-owned company aims to reduce GPU costs by one-tenth and provide custom-designed NAND storage for AI, enterprise, and automotive industries.
stock market ticker ✌️【Non-Full-Time】✌️Make your ₹500 grow rapidly with AI-backed investments.With a $250 million investment and plans to expand to 1,000 employees, MiPhi is supported by the government and welcomes chip design startups.stock market ticker Smart Fund Investments for Steady Growth